ReviewJournal of experimental & clinical cancer research : CR2023

Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance.

Ting-Wan Kao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.